Review




Structured Review

Jackson Laboratory wild type c57bl6 j mice
Wild Type C57bl6 J Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wild type c57bl6 j mice/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
wild type c57bl6 j mice - by Bioz Stars, 2026-06
86/100 stars

Images



Similar Products

99
Inotiv wild type c57bl6 j mice
VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
Wild Type C57bl6 J Mice, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wild type c57bl6 j mice/product/Inotiv
Average 99 stars, based on 1 article reviews
wild type c57bl6 j mice - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

86
Jackson Laboratory wild type c57bl6 j mice
VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
Wild Type C57bl6 J Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wild type c57bl6 j mice/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
wild type c57bl6 j mice - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Jackson Laboratory mouse lines c57bl6 j wild type mice
VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
Mouse Lines C57bl6 J Wild Type Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse lines c57bl6 j wild type mice/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
mouse lines c57bl6 j wild type mice - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Jackson Laboratory type c57bl6 j mice
VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
Type C57bl6 J Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/type c57bl6 j mice/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
type c57bl6 j mice - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Charles River Laboratories wild type c57bl6 j mice
VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
Wild Type C57bl6 J Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wild type c57bl6 j mice/product/Charles River Laboratories
Average 86 stars, based on 1 article reviews
wild type c57bl6 j mice - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Charles River Laboratories female c57bl6 j wild type mice
VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
Female C57bl6 J Wild Type Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/female c57bl6 j wild type mice/product/Charles River Laboratories
Average 86 stars, based on 1 article reviews
female c57bl6 j wild type mice - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Jackson Laboratory animals female c57bl6 j wild type mice
VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
Animals Female C57bl6 J Wild Type Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/animals female c57bl6 j wild type mice/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
animals female c57bl6 j wild type mice - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, wild-type. All scale bars, 250 μm.

Journal: iScience

Article Title: Response dynamics of discrete subiculum→retrosplenial cortex projections underlying trace fear conditioning

doi: 10.1016/j.isci.2026.115317

Figure Lengend Snippet: VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, wild-type. All scale bars, 250 μm.

Article Snippet: Wild type C57BL6/J mice were purchased from Harlan, Indianapolis, IN.

Techniques: Virus, Expressing, Injection